CVE-2026-118468 - Vulnerability Details - OpenCVE

XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks.

Attack Vector Network

Attack Complexity High

Privileges Required None

Attack Requirements Present

User Interaction None

Vulnerable System Confidentiality Impact High

Vulnerable System Integrity Impact High

Vulnerable System Availability Impact High

Subsequent System Confidentiality Impact None

Subsequent System Integrity Impact None

Subsequent System Availability Impact None

No CVSS v3.1

No CVSS v3.0

No CVSS v2

This CVE is not in the KEV list.

No EPSS score available.

Key SSVC decision points have not yet been added.

No data.

No data.

No data.

No data.

Advisories

No advisories yet.

Fixes

Solution

No solution given by the vendor.

Workaround

No workaround given by the vendor.

References

Link	Providers
https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical
https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html

History

Mon, 09 Nov 2026 12:00:00 +0000

Type	Values Removed	Values Added
Description		XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks.
Title		AIS XML parsers allow external entity resolution
Weaknesses		CWE-611
References		https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html
Metrics		cvssV4_0 `{'score': 7.2, 'vector': 'CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U'}`

Projects

Sign in to view the affected projects.

MITRE

Status: PUBLISHED

Assigner: ENISA

Published: 2026-11-09T11:58:12.438Z

Updated: 2026-11-09T11:58:12.438Z

Reserved: 2026-10-28T08:46:25.411Z

Link: CVE-2026-118468

Vulnrichment

No data.

NVD

Status : Received

Published: 2026-11-09T12:16:37.710

Modified: 2026-11-09T12:16:37.710

Link: CVE-2026-118468

Redhat

No data.

OpenCVE Enrichment

No data.

Weaknesses

CWE-611

{"dataType": "CVE_RECORD", "dataVersion": "5.2", "cveMetadata": {"cveId": "CVE-2026-118468", "assignerOrgId": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "state": "PUBLISHED", "assignerShortName": "ENISA", "dateReserved": "2026-10-28T08:46:25.411Z", "datePublished": "2026-11-09T11:58:12.438Z", "dateUpdated": "2026-11-09T11:58:12.438Z"}, "containers": {"cna": {"providerMetadata": {"orgId": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "shortName": "ENISA", "dateUpdated": "2026-11-09T11:58:12.438Z"}, "title": "AIS XML parsers allow external entity resolution", "problemTypes": [{"descriptions": [{"lang": "en", "cweId": "CWE-611", "description": "CWE-611", "type": "CWE"}]}], "affected": [{"vendor": "CompuGroup Medical", "product": "Infantia", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "6.01.1", "versionType": "semver"}], "defaultStatus": "unaffected"}, {"vendor": "CompuGroup Medical", "product": "Profim", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "6.01.1", "versionType": "semver"}], "defaultStatus": "unaffected"}, {"vendor": "CompuGroup Medical", "product": "Phronesis", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "4.51.0", "versionType": "semver"}], "defaultStatus": "unaffected"}, {"vendor": "CompuGroup Medical", "product": "Venere", "versions": [{"status": "affected", "version": "0", "lessThanOrEqual": "8.33.2", "versionType": "semver"}], "defaultStatus": "unaffected"}], "descriptions": [{"lang": "en", "value": "XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks.", "supportingMedia": [{"type": "text/html", "base64": false, "value": "XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks."}]}], "references": [{"url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical"}, {"url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html"}], "metrics": [{"format": "CVSS", "scenarios": [{"lang": "en", "value": "GENERAL"}], "cvssV4_0": {"attackVector": "NETWORK", "attackComplexity": "HIGH", "attackRequirements": "PRESENT", "privilegesRequired": "NONE", "userInteraction": "NONE", "vulnConfidentialityImpact": "HIGH", "subConfidentialityImpact": "NONE", "vulnIntegrityImpact": "HIGH", "subIntegrityImpact": "NONE", "vulnAvailabilityImpact": "HIGH", "subAvailabilityImpact": "NONE", "exploitMaturity": "UNREPORTED", "Safety": "NOT_DEFINED", "Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "valueDensity": "NOT_DEFINED", "vulnerabilityResponseEffort": "NOT_DEFINED", "providerUrgency": "NOT_DEFINED", "version": "4.0", "baseSeverity": "HIGH", "baseScore": 7.2, "vectorString": "CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U"}}], "credits": [{"lang": "en", "value": "Marco Sala", "type": "finder"}, {"lang": "en", "value": "CSIRT-IT", "type": "coordinator"}, {"lang": "en", "value": "ApoCert srl", "type": "finder"}], "x_generator": {"engine": "Vulnogram 1.0.5"}, "source": {"discovery": "UNKNOWN"}}}}

{"affected": [{"affectedData": [{"defaultStatus": "unaffected", "product": "Infantia", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "6.01.1", "status": "affected", "version": "0", "versionType": "semver"}]}, {"defaultStatus": "unaffected", "product": "Profim", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "6.01.1", "status": "affected", "version": "0", "versionType": "semver"}]}, {"defaultStatus": "unaffected", "product": "Phronesis", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "4.51.0", "status": "affected", "version": "0", "versionType": "semver"}]}, {"defaultStatus": "unaffected", "product": "Venere", "vendor": "CompuGroup Medical", "versions": [{"lessThanOrEqual": "8.33.2", "status": "affected", "version": "0", "versionType": "semver"}]}], "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158"}], "cveTags": [], "descriptions": [{"lang": "en", "value": "XML parsers process attacker-influenced update manifests or network responses with external entity resolution enabled, potentially allowing XML External Entity (XXE) attacks."}], "id": "CVE-2026-118468", "lastModified": "2026-11-09T12:16:37.710", "metrics": {"cvssMetricV40": [{"cvssData": {"Automatable": "NOT_DEFINED", "Recovery": "NOT_DEFINED", "Safety": "NOT_DEFINED", "attackComplexity": "HIGH", "attackRequirements": "PRESENT", "attackVector": "NETWORK", "availabilityRequirement": "NOT_DEFINED", "baseScore": 7.2, "baseSeverity": "HIGH", "confidentialityRequirement": "NOT_DEFINED", "exploitMaturity": "UNREPORTED", "integrityRequirement": "NOT_DEFINED", "modifiedAttackComplexity": "NOT_DEFINED", "modifiedAttackRequirements": "NOT_DEFINED", "modifiedAttackVector": "NOT_DEFINED", "modifiedPrivilegesRequired": "NOT_DEFINED", "modifiedSubAvailabilityImpact": "NOT_DEFINED", "modifiedSubConfidentialityImpact": "NOT_DEFINED", "modifiedSubIntegrityImpact": "NOT_DEFINED", "modifiedUserInteraction": "NOT_DEFINED", "modifiedVulnAvailabilityImpact": "NOT_DEFINED", "modifiedVulnConfidentialityImpact": "NOT_DEFINED", "modifiedVulnIntegrityImpact": "NOT_DEFINED", "privilegesRequired": "NONE", "providerUrgency": "NOT_DEFINED", "subAvailabilityImpact": "NONE", "subConfidentialityImpact": "NONE", "subIntegrityImpact": "NONE", "userInteraction": "NONE", "valueDensity": "NOT_DEFINED", "vectorString": "CVSS:4.0/AV:N/AC:H/AT:P/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:U/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X", "version": "4.0", "vulnAvailabilityImpact": "HIGH", "vulnConfidentialityImpact": "HIGH", "vulnIntegrityImpact": "HIGH", "vulnerabilityResponseEffort": "NOT_DEFINED"}, "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "type": "Secondary"}]}, "published": "2026-11-09T12:16:37.710", "references": [{"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "url": "https://www.acn.gov.it/portale/w/rilevate-vulnerabilita-in-prodotti-compugroup-medical"}, {"source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "url": "https://www.cgm.com/ita_it/magazine/articles/comunicati-stampa/piu-sicurezza-per-farmacie-studi-medici-e-pazienti-cgm-italia-risolve-potenziali-vulnerabilita-software-insieme-a-csirt-italia.html"}], "sourceIdentifier": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "vulnStatus": "Received", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-611"}], "source": "a6d3dc9e-0591-4a13-bce7-0f5b31ff6158", "type": "Secondary"}]}